Neuralink's Modern Brain-Chip Innovation: Improved Efficiency with Fewer Electrodes

Elon Musk's Neuralink is developing a brain-chip that uses fewer electrodes for enhanced efficiency. The company also adjusts risk mitigation by sculpting skulls and normalizing blood carbon dioxide levels. These steps follow issues experienced by the first trial participant involving implant wires.

Elon Musk's brain-chip company, Neuralink, is advancing a new device designed to increase efficiency by utilizing half the number of electrodes typically required, according to company executives.

Additionally, Neuralink is incorporating risk mitigation measures, such as skull sculpting and stabilizing blood carbon dioxide levels, as explained in a live stream on social media platform X. These measures come in response to problems encountered by the first trial participant with implant wires.